Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Efficacy and Tolerability of Glucomannan on Children Affected by NAFLD

NCT01553500 is registered in ClinicalTrials.gov with Bambino Gesù Hospital and Research Institute as lead sponsor.

NCT NCT01553500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Efficacy and Tolerability of Glucomannan on Children Affected by NAFLD
Lead sponsor
Bambino Gesù Hospital and Research Institute
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2013
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, metabolic syndrome, non alcoholic fatty liver disease